University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Obviously caveats must be drawn from a mouse model such as this, but the results have supercharged the team's determination.

The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, according to an industry press release. The implantable device (Portal ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked ...

The designation supports priority engagement with the FDA as Portal Diabetes advances clinical trials and regulatory ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

Portal Diabetes has received Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable insulin pump system called Portal Pump, and the start of ...

Researchers linked insulin resistance to 12 types of cancer, with uterine cancer showing the strongest connection at 134% ...

Insulin is rising in cost despite its necessity for survival for people with diabetes. Patent evergreening by insulin manufacturers hinders competition and keeps prices high. Congress should pass ...

People with diabetes who are treated with insulin have more than a 60% increased risk of being hospitalized for injuries which include head and neck trauma, and burns, compared to the general ...

DAVAO CITY - The Provincial Health Office of Davao Oriental will decentralize the distribution of free insulin to children ...